Resumen Introducción: Las cardiopatías congénitas son las anomalías congénitas más comunes en recién nacidos con una prevalencia de 1%. El cateterismo cardíaco diagnóstico y terapéutico ha revolucionado el tratamiento de estas enfermedades, aunque puede acompañarse de complicaciones. Objetivo: Describir la incidencia y el tipo de complicaciones vinculadas con el cateterismo cardíaco pediátrico en un centro de referencia para cardiopatías congénitas. Método: Estudio observacional retrospectivo, con intención analítica a partir de registros de cateterismos cardíacos realizados a pacientes con cardiopatías congénitas y adquiridas. Resultados: Se incluyeron 2,688 registros durante nueve años consecutivos. El 53.9% correspondió a hombres, 21.3% con edades de dos a cinco años y 20.3% de seis meses a dos años. El 63.5% de los procedimientos fue electivo. La prevalencia de complicaciones en las primeras 24 horas posteriores al cateterismo fue de 6.7% (4.2% menores y 2.4% mayores). En el 0.8% de los procedimientos sobrevino la muerte temprana. Los factores relacionados con las complicaciones fueron: edad al momento del cateterismo <28 días (OR, 2.18; IC 95%, 1.28-3.70), saturación de oxígeno antes del cateterismo <79% (OR, 2.15; IC 95%, 1.02-4.53), uso de inotrópicos antes del cateterismo (OR, 3.00; IC 95%, 1.68-5.33). Las variables incluidas en el modelo explican el 38% de la varianza de las complicaciones posteriores al cateterismo cardíaco en pacientes menores de 18 años. Conclusiones: En este estudio, el cateterismo cardíaco se vinculó con complicaciones mayores y menores, incluida la muerte. Los factores adjuntos fueron edad menor de 28 días, menor saturación de oxígeno y uso de inotrópicos antes del cateterismo.
Ventricular diverticulum is a rare congenital malformation. Although most patients are asymptomatic, it can present with rupture and sudden death, for which surgical repair is indicated. The authors report the case of a 5-year-old boy with a prenatal diagnosis of an isolated left ventricular diverticulum. It was decided for surgical closure; however, a persisting leakage at the patch repair site was observed, for which a transcatheter percutaneous closure approach was used, achieving complete occlusion of the defect. Transcatheter closure of suitable ventricular diverticula is a safe and effective option.
Introduction:Congenital heart diseases are the most common congenital abnormalities in newborns with a prevalence of 1%. Therapeutic and diagnostic cardiac catheterization has revolutionized the treatment of these diseases; however, it can be associated with complications. Objective: To describe the incidence and type of complications associated with pediatric cardiac catheterization in a reference center for congenital heart defects. Methodology: Retrospective observational study, with analytical intention based on records of cardiac catheterization, performed on patients with congenital and acquired heart disease. Results: Two thousand six hundred and eighty-eight records were included for nine consecutive years. About 53.9% were men, 21.3% with ages between 2 and 5 years, and 20.3% between 6 months and 2 years. About 63.5% of the procedures were elective. The prevalence of complications in the first 24 h after catheterization was 6.7% (4.2% minor and 2.4% major). Early death occurred in 0.8% of the procedures. Factors associated with complications were age at catheterization < 28 days (odds ratio OR 2.18,), precatheter oxygen saturation < 79% (OR 2.15,), use of pre-catheter inotropics (OR 3.00,). The variables included in the model explain 38% of the variance of post-cardiac catheterization complications in patients younger than 18 years. Discussion: Cardiac catheterization is associated with major and minor complications including death. The associated factors were < 28 days, lower oxygen saturation, and use of pre-catheter inotropics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.